We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

276 hedge funds and large institutions have $7.7B invested in CUBIST PHARMACEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 105 increasing their positions, 107 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $7.35B → $7.7B (+$358M)

3% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 35

0% more funds holding

Funds holding: 276276 (0)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

2% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 107

38% less call options, than puts

Call options by funds: $17.2M | Put options by funds: $27.8M

Holders
276
Holders Change
Holders Change %
0%
% of All Funds
7.97%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.23%
New
36
Increased
105
Reduced
107
Closed
35
Calls
$17.2M
Puts
$27.8M
Net Calls
-$10.6M
Net Calls Change
-$140M
Name Holding Trade Value Shares
Change
Change in
Stake
AB
201
Amalgamated Bank
New York
$561K -$3.8K -51 -0.7%
CI
202
Cowen Inc
New York
$558K +$345K +4,625 +154%
PNC Financial Services Group
203
PNC Financial Services Group
Pennsylvania
$557K +$28.8K +386 +5%
CAM
204
Capstone Asset Management
Texas
$547K -$13.4K -180 -2%
WAM
205
World Asset Management
Michigan
$526K +$7.16K +96 +1%
US Bancorp
206
US Bancorp
Minnesota
$507K -$37.2K -499 -7%
PCP
207
Perimeter Capital Partners
Georgia
$500K -$7.53K -101 -1%
PP
208
PDT Partners
New York
$493K +$7.46K +100 +2%
IPC
209
Independent Portfolio Consultants
Florida
$453K -$746 -10 -0.2%
RFS
210
Rockefeller Financial Services
New York
$451K -$8.65K -116 -2%
MLL
211
Moody Lynn & Lieberson
Massachusetts
$443K -$37.9K -508 -8%
Asset Management One
212
Asset Management One
Japan
$430K -$18.6K -249 -4%
Thrivent Financial for Lutherans
213
Thrivent Financial for Lutherans
Minnesota
$421K +$3.73K +50 +0.9%
WFM
214
Wilmington Funds Management
Delaware
$415K -$133K -1,789 -24%
Two Sigma Advisers
215
Two Sigma Advisers
New York
$413K +$421K +5,646 New
QIM
216
Quest Investment Management
Oregon
$411K -$74.9K -1,005 -15%
TAM
217
Tocqueville Asset Management
New York
$410K
VAM
218
Visium Asset Management
New York
$386K -$740K -9,928 -65%
Commonwealth Equity Services
219
Commonwealth Equity Services
Massachusetts
$380K -$155K -2,075 -29%
TH
220
Timber Hill
Connecticut
$374K -$41.8K -561 -10%
JC
221
JBF Capital
Colorado
$373K +$380K +5,100 New
AL
222
Airain Ltd
Guernsey
$348K +$355K +4,757 New
Jane Street
223
Jane Street
New York
$345K +$352K +4,723 New
AG
224
Aperio Group
California
$344K +$351K +4,706 New
PFC
225
Phocas Financial Corp
California
$326K

CBST Hedge Fund Activity: Q1 2014 in Review

276 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q1 2014, worth a combined $7.7B — up 4.9% from $7.35B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new CBST positions and 35 closed out — a net gain of 1 holder — while 105 added to existing stakes and 107 trimmed.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $636M. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $66M.

  • 276 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $7.7B of CUBIST PHARMACEUTICALS INC stock for Q1 2014, up 4.9% quarter-over-quarter.
  • 36 funds opened new CUBIST PHARMACEUTICALS INC positions in Q1 2014 and 35 closed out, a net change of +1 holder.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q1 2014 was BNP Paribas Financial Markets, an estimated $636M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q1 2014 was Canada Pension Plan Investment Board, an estimated $66M sold.

Based on aggregated 13F filings for Q1 2014.